Abiopharma

FDA approve DIAZEPAM

FDA approve RIVASTIGMINE

NYSE MKT symbol attribute type Security_Name was changed. Previous value: -. New value: AIM ImmunoTech Inc. Common Stock.

NYSE MKT symbol attribute type Test_mode was changed. Previous value: -. New value: N.

SciBase has signed a Collaboration and License Agreement with Castle Biosciences to develop diagnostic tests within dermatology and intends to carry out a directed share issue of approximately MSEK 30

The Unexpected Side Effect of AI: Why Entry-Level Tech Jobs Are Now at Risk

Pixel Drop June 2025: 8 New AI Features That Could Change How You Use Your Phone Forever

Beyond the Search Bar: How Bing’s Latest Updates Aim to Disrupt Google’s Dominance (And What It Means for You)

Innate Pharma - Innate Pharma Announces Its Participation in H.C. Wainwright and Wolfe Research Healthcare Conferences

The AI Arms Race: How Microsoft’s Copilot and Google’s Gemini Are Redefining Productivity in 2025

FDA approve SODIUM IODIDE I-131

Innate Pharma Announces Its Participation in H.C. Wainwright and Wolfe Research Healthcare Conferences

Q & M Dental Group (Singapore) Limited - Announcement

Cordlife Group Limited - Announcement

Employee Stock Option/ Share Scheme: ISSUANCE OF SHARES PURSUANT TO ENTERPRISE OPTION SCHEME